Company intelligence / Profile preview

DD-Hippero

Shijiazhuang, Hebei, Chinaceginformacio.hu ↗

Ownership: Private
Development stage: Other

Overview

Hipro Biotechnology is a leading developer and manufacturer of diagnostic system solutions for point-of-care testing. The company offers over 75 diagnostic parameters using biochemistry, nephelometry, fluorescence, and turbidimetric technologies. Their products are CE certified and ISO 13485 compliant.

Therapeutic areas: Other
Modalities: DeviceDiagnostic reagent
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on DD-Hippero.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DD-Hippero.

Explore the full profile